electrospray ionisation is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-11-21. Numbers and descriptions here follow the published literature rather than marketing material.
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.
The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.
Selectivity is the property most often attached to this peptide. Published animal and early human studies record increases in growth hormone release after administration, with adrenocorticotropic hormone and cortisol responses remaining small by comparison. Effects on appetite-related pathways also appear weaker than those reported for several earlier secretagogues. Reviews that compare members of the growth hormone secretagogue family cite these findings frequently, though the receptor-level explanation for the selectivity continues to be debated rather than settled.
Material supplied for research use is normally a white to off-white lyophilized powder. The solid is hygroscopic and is handled in a low-humidity environment to limit water uptake. Bulk quantities are frequently shipped in sealed vials under inert gas. Once reconstituted in water or a neutral buffer, the solution is less stable than the dry powder and is usually divided into single-use aliquots.
Long-term storage of the dry powder is typically at minus twenty degrees Celsius or lower, protected from light and moisture. Solutions are commonly kept frozen and thawed only once, because repeated freeze-thaw cycles can promote aggregation and loss of measurable peptide content. Buffers near neutral pH are preferred over strongly acidic or strongly basic conditions. Shipping at ambient temperature is acceptable for short periods when the powder remains sealed and desiccated.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C38H49N9O5 | Pentapeptide with C-terminal amide |
| Average mass | Approximately 711.9 Da | Value derived from the formula |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water and aqueous acetonitrile | Dissolution aided by acidic diluents |
| Common synonyms | Ipamorelin; NNC 26-0161 | Code name used in early reports |
Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.
The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.
Ipamorelin is a synthetic pentapeptide first described in the 1990s by researchers at Novo Nordisk during a program to develop selective growth hormone secretagogues. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, incorporating two non-natural residues, alpha-aminoisobutyric acid and D-2-naphthylalanine. The C-terminus is amidated, and the material is supplied as a white lyophilized powder. The molecular formula is C38H49N9O5 and the monoisotopic mass is approximately 711.85 daltons. The short chain and modified residues give it greater resistance to enzymatic degradation than many larger peptide hormones.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor type 1a, the same G protein-coupled receptor that binds ghrelin. Receptor activation couples to Gq/11 signaling, raising intracellular calcium through inositol trisphosphate and diacylglycerol, which in turn promotes exocytosis of growth hormone from pituitary somatotroph cells. Ipamorelin binds this receptor with high affinity and shows weak activity at other secretagogue-related targets in vitro. Its action requires the intact receptor and is not reversed by growth hormone-releasing hormone antagonists.
Compared with earlier growth hormone secretagogues such as GHRP-6 and hexarelin, ipamorelin has been reported to produce less stimulation of adrenocorticotropic hormone, cortisol, and prolactin in animal and early human studies. This selectivity is usually attributed to differences in receptor subtype interactions and to the tissue distribution of the receptor. Effects on appetite appear weaker than those of ghrelin itself, although the supporting evidence base is small. Whether these differences produce a distinct clinical profile remains an open question, since controlled human trials are limited.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
=== Refugees === On January 20, 2025, Trump signed the executive order named "Securing Our Borders". This order suspends the Uniting for Ukraine parole program, and no new applications from Ukrainian refugees with relatives in the United States are being accepted. On May 12, 59 white South African refugees arrived from South Africa. The Trump administration has been criticized for fast-tracking their applications while pausing other refugee programs. The Trump administration slowed the entry of Afghan refugees into the U.S., including persons who had fought on the U.S. side against the Taliban. A leader of an American veterans group said, "these pilots risked everything for America. Their lives are now on the line because of our failure to follow through on our promises." On May 12, Department of Homeland Security Secretary Noem announced that TPS, or temporary protected status, for Afghan refugees would be ended in 60 days, which is the shortest time period permitted by United States law. This decision cited improved conditions in Afghanistan. The Hill reports that the UN high commissioner for refugees has stated that the situation in Afghanistan has not improved, with a report stating "The large-scale returns are putting even greater pressure on already stretched humanitarian resources." On the other hand, Secretary Noem has pointed to an increase in tourists from China and a drop in the number of Afghans needing assistance from 29 million to 24 million.
=== SB Pharmco Puerto Rico === In 2010, the US Department of Justice announced that GSK would pay a US$150 million criminal fine and forfeiture, and a civil settlement of US$600 million under the False Claims Act. The fines stemmed from production of improperly made and adulterated drugs from 2001 to 2005, at GSK's subsidiary, SB Pharmco Puerto Rico Inc., in Cidra, Puerto Rico, which at the time produced US$5.5 billion of products each year. The drugs involved were Kytril, an antiemetic; Bactroban, used to treat skin infections; Paxil, the anti-depressant; and Avandamet, a diabetes drug. GSK closed the factory in 2009. The case began in 2002, when GSK sent experts to fix problems cited by the FDA. The lead inspector recommended recalls of defective products, but they were not authorised; she was fired in 2003, and filed a whistleblower lawsuit. In 2005, federal marshals seized US$2 billion worth of products, the largest such seizure in history. In the 2010 settlement SB Pharmco pleaded guilty to criminal charges, and agreed to pay US$150 million in a criminal fine and forfeiture, at that time the largest such payment ever by a manufacturer of adulterated drugs, and US$600 million in civil penalties to settle the civil lawsuit.
Laboratory robotics is the act of using robots in biology, chemistry or engineering labs. For example, pharmaceutical companies employ robots to move biological or chemical samples around to synthesize novel chemical entities or to test pharmaceutical value of existing chemical matter. Advanced laboratory robotics can be used to completely automate the process of science, as in the Robot Scientist project. Laboratory processes are suited for robotic automation as the processes are composed of repetitive movements (e.g., pick/place, liquid/solid additions, heating/cooling, mixing, shaking, and testing). Many laboratory robots are commonly referred as autosamplers, as their main task is to provide continuous samples for analytical devices.
Sources: en.wikipedia.org
Before pregnancy, people with EDS may be recommended to have genetic counseling and to familiarize themselves with the risks pregnancy poses. Children with EDS should be given information about the disorder so they can understand why they should avoid contact sports and other physically stressful activities. Children should be taught that they should not demonstrate the unusual positions they can maintain due to loose joints, as this may cause early degeneration of the joints. Emotional support, along with behavioral and psychological therapy, can be useful. Support groups can be immensely helpful for people dealing with major lifestyle changes and poor health. Family members, teachers, and friends should be informed about EDS so they can accept and assist the child.
Wound healing is classically divided into hemostasis, inflammation, proliferation, and remodeling. Although a useful construct, this model employs considerable overlapping among individual phases. A complementary model has recently been described where the many elements of wound healing are more clearly delineated. The importance of this new model becomes more apparent through its utility in the fields of regenerative medicine and tissue engineering (see Research and development section below). In this construct, the process of wound healing is divided into two major phases: the early phase and the cellular phase: Electrospun nanofiber-based wound dressings have attracted increasing attention because their porous architecture and high surface-area-to-volume ratio can mimic the extracellular matrix, thereby supporting cell adhesion, proliferation, and tissue regeneration. The early phase, which begins immediately following skin injury, involves cascading molecular and cellular events leading to hemostasis and formation of an early, makeshift extracellular matrix that provides structural staging for cellular attachment and subsequent cellular proliferation. The cellular phase involves several types of cells working together to mount an inflammatory response, synthesize granulation tissue, and restore the epithelial layer. Subdivisions of the cellular phase are:
Space Invaders, originally released for arcades in 1978, became a killer app when it was ported to the Atari VCS console in 1980, quadrupling sales of the three-year-old console. Star Raiders, released in 1980, was the first killer app computer game. BYTE named it the single most important reason for sales of Atari 400 and 800 computers. Another was Eastern Front (1941), released in 1981. In 1996, Computer Gaming World wrote that Wizardry: Proving Grounds of the Mad Overlord (1981) "sent AD&D fans scrambling to buy Apple IIs". The Famicom home port of Xevious is considered the console's first killer app, which caused system sales to jump by nearly 2 million units. Computer Gaming World stated that The Legend of Zelda on the Nintendo Entertainment System, Phantasy Star II on the Sega Genesis, and Far East of Eden for the NEC TurboGrafx-16 were killer apps for their consoles. The Super Mario, Final Fantasy, and Dragon Quest series were killer apps for Nintendo's Famicom and Super Famicom consoles in Japan. John Madden Football's popularity in 1990 helped the Genesis gain market share against the Super NES in North America. Sonic the Hedgehog, released in 1991, was hailed as a killer app as it revived sales of the three-year-old Genesis. Mortal Kombat helped pushed the sales of the Genesis due to being uncensored unlike the Nintendo version. Streets of Rage became a system seller for the Mega Drive/Genesis in the UK. Street Fighter II, originally released for arcades in 1991, became a system-seller for the Super NES when it was ported to the platform in 1992.
== Middle Ages == With the fall of the western Roman Empire in 476, Italy was taken over by the Germanic chieftain Odoacer and later became part of the Ostrogothic Kingdom in 489. The Ostrogothic kings ruled officially as Magistri Militum of the Byzantine Emperors. All government and administrative positions were held by Romans, while all primary laws were legislated by the Byzantine Emperor. During the sixth century, under the Ostrogoths' rule, Romans remained the center of government and cultural life. The Roman Cassiodorus, like Boethius and Symmachus, emerged as one of the most prominent men of his time. He was an administrator, politician, scholar and historian who was born in Scylletium (near Catanzaro). He spent most of his career trying to bridge the divides of East and West, Greek and Latin cultures, Romans and Goths, and official Christianity and Arian Christianity, which was the form of Christianity adopted by the Ostrogoths and which had earlier been banned. He established the Vivarium (monastery) in Scylletium. He oversaw the collation of three editions of the Bible in Latin. Seeing the value of collecting all the books of the Bible in one volume, he was the first to produce Latin Bibles in single volumes. The most well-known was the Codex Grandior which became the ancestor of all modern western Bibles. Cassiodorus was the heart of the administration of the Ostrogothic kingdom.
Sources: en.wikipedia.org
== Paleontology == If the conditions are good, chemical gardens can also occur in nature. There is evidence from paleontology that such chemical gardens may fossilize. Such pseudofossils can be very difficult to distinguish from fossilized organisms. Indeed, some of the earliest purported fossils of life might be fossilized chemical gardens. Mixing iron-rich particles with alkaline liquids containing the chemicals silicate or carbonate have created biological-looking structures. Such structures may appear to be biological structures and/or fossils. According to researchers, "Chemical reactions like these have been studied for hundreds of years but they had not previously been shown to mimic these tiny iron-rich structures inside rocks. These results call for a re-examination of many ancient real-world examples to see if they are more likely to be fossils or non-biological mineral deposits." One use of the study of chemical gardening is to be better able to distinguish biological structures, including fossils, from non-biological structures on the planet Mars.
=== Muscle tone === Individuals with decreased muscle tone, increased soft tissue around the airway, and structural features that narrow the airway are at high risk for OSA. Men, whose anatomy is typified by increased mass in the torso and neck, are at increased risk of developing sleep apnea, especially in middle age and later. Typically, women experience this condition less frequently and to a lesser degree than do men, owing partially to physiology, but possibly also to differential levels of progesterone. Prevalence in post-menopausal women approaches that of men in the same age range. Women are at greater risk for developing OSA during pregnancy.
=== PE Corporation === In 1999, to focus on the new genomics, Perkin-Elmer Corporation was renamed PE Corporation, and sold its old Analytical Instruments division to EG&G, Inc., which also acquired the Perkin-Elmer name. PE Biosystems remained with PE Corp., and became PE Biosystems Group, with 3,500 employees and net revenues of over $1.2 billion. New instruments were developed and sold for forensic human identification, protein identification and characterization, metabolite pathway identification, and lead compound identification from combinatorial libraries. On April 27, 1999, the shareholders of Perkin-Elmer Corporation approved the reorganization of Perkin-Elmer into PE Corporation, a pure-play life science company. Each share of the Perkin-Elmer stock (PKN) was to be exchanged for one share and for +1⁄2 of a share respectively of the two new common share tracking stocks for the two component Life Sciences groups, PE Biosystems Group and Celera Genomics Group. On April 28, 1999, the two replacement tracking stocks for the new PE Corporation were issued to shareholders. Dr. Michael W. Hunkapiller remained as a Senior Vice President of PE Corporation, and as president of PE Biosystems. On May 6, 1999, the recapitalization of the company resulted in issuance of the two new classes of common stock, called PE Corporation-PE Biosystems Group Common Stock and PE Corporation-Celera Genomics Group Common Stock. On that date, trading began in both new stocks on the New York Stock Exchange, to great excitement.
Sources: en.wikipedia.org
It is a synthetic five-amino-acid peptide that acts as a growth hormone secretagogue. Three of its residues are non-standard amino acids, and the chain ends in an amide rather than a free acid. The molecule is small enough that it can be characterised by routine peptide analytical techniques.
It has not received marketing approval as a medicine in the United States or the European Union. Supplied material is generally described and handled as a research chemical. Regulatory treatment varies by jurisdiction, and some countries restrict growth hormone secretagogues under sports or medicines legislation.
Earlier secretagogues were associated with broader hormonal responses, including measurable changes in cortisol and prolactin. Reports on this peptide describe a narrower profile in which growth hormone release is the most prominent effect. The observation is influential because it shapes how the compound is compared with other members of the same receptor family.
Dry powder is held at minus twenty degrees Celsius or colder, away from light and moisture. Sealed vials under inert gas limit degradation during storage.